Jane Street’s Terns Pharmaceuticals TERN Stock Holding History

Jane Street’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.3M	Sell	290,100 -46,100	-14%	-$1.89M	﹤0.01%	2039
2025 Q4	$13.6M	Buy	336,200 +213,700	+174%	+$4.94M	﹤0.01%	1964
2025 Q3	$920K	Buy	+122,500	New	+$782K	﹤0.01%	6478
2025 Q2	–	Sell	-11,500	Closed	-$31.7K	–	10871
2025 Q1	$31.7K	Sell	11,500 -14,200	-55%	-$58K	﹤0.01%	9082
2024 Q4	$142K	Sell	25,700 -70,300	-73%	-$476K	﹤0.01%	8608
2024 Q3	$801K	Buy	96,000 +78,100	+436%	+$643K	﹤0.01%	6311
2024 Q2	$122K	Buy	+17,900	New	+$108K	﹤0.01%	8655
2024 Q1	–	Sell	-21,900	Closed	-$142K	–	10067
2023 Q4	$142K	Sell	21,900 -1,400	-6%	-$7.4K	﹤0.01%	8422
2023 Q3	$117K	Sell	23,300 -17,600	-43%	-$112K	﹤0.01%	7885
2023 Q2	$358K	Buy	+40,900	New	+$477K	﹤0.01%	6851

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Jane Street's TERN Position: Q1 2026 in Review

Jane Street reduced its Terns Pharmaceuticals (TERN) stake by 92% in Q1 2026, selling an estimated $3.35M and leaving 7,231 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8664.

Jane Street first reported a position in TERN in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.59M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Jane Street held 7,231 shares of Terns Pharmaceuticals worth $381K as of Q1 2026.
Jane Street sold 81,606 Terns Pharmaceuticals shares in Q1 2026, an estimated $3.35M.
Terns Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8664 holding.
Jane Street first reported a position in Terns Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
Jane Street's Terns Pharmaceuticals position peaked at $3.59M in Q4 2025.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.